Requisite Capital Management, LLC Gilead Sciences, Inc. Transaction History

Requisite Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $180,090 - $226,432	-2,900 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $187,890 - $240,660	-3,000 Reduced 50.85%	2,900 $217,000
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $61,870 - $69,380	1,000 Added 20.41%	5,900 $399,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $306,397 - $343,245	4,900 New	4,900 $319,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Requisite Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Requisite Capital Management, LLC with notifications on news.